Chromogenics (EN) Chromogenics (SV) START ABOUT TECHNOLOGY PRODUCTS NEWS INVESTORS & PARTNERS ChromoGenics has signed order for energy efficient smart windows to office building in Uppsala 2017-10-03 ChromoGenics AB (publ) has signed an agreement with the real estate company Saldeen Real Estate AB about providing dynamic glass for solar control to an existing office property in Uppsala. The energy-saving windows replaced the previous solar protection solution. "The office has previously had extensive problems with dazzling sun and high heat irradiation. A lot of cooling has been needed to lower the temperature, which required a lot of energy. With ChromoGenics’ energy-efficient technology, cooling needs have decreased and the indoor climate has become much more comfortable since the windows were installed. The tenants are satisfied and that makes med glad too," said Bo Saldeen, CEO of Saldeen Real Estate. Bo Saldeen previously considered investing in a larger cooling system and exterior solar protection, but the options were discarded due to that maintenance costs for awnings and similar solutions are often high, they change the appearance of the façades and daylight is deprived. “We have improved our working environment with a more comfortable climate and the dazzling sun rays are no longer a problem. In addition, we get the daylight people need and there is no longer need for curtains that shut the daylight out," says Fredrik Larsson, COO at VHD-Media, whose office is in the property. “Satisfied tenants are important to all property owners and we are pleased that our dynamic glass can contribute to it, while reducing environmental impact through lower energy consumption. Sustainability is high on the agenda for all property owners,” says Thomas Almesjö, CEO of ChromoGenics. “The order shows a need for property owners to upgrade their existing properties with energy efficient solutions. It is possible to save a lot of energy in existing properties and premises, thereby lowering carbon dioxide emissions," concludes Thomas Almesjö. ChromoGenics’ dynamic glass automatically controls heat and light emitting on premises, providing better indoor comfort and lower energy consumption. The cooling need of premises can be reduced by 20-40 percent. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-10-03 order_Saldeen Real Estate_ENG.pdf Share News Press Releases PRESS RELEASES ChromoGenics’ seminar creates interest in the building and real estate sector for a sustainable society ChromoGenics AB (publ) welcomed guests from the real estate industry to Dynamic Glass Academy, a seminar on energy efficiency and comfort in building focused on sustainability. To meet the great interest in the company's dynamic glass ConverLight™, ChromoGenics invited architects, real estate companies, energy consultants and other stakeholders in the real estate industry in Uppsala to another seminar "Dynamic Glass Academy". Guest speakers presented the latest in sustainability trends, energy efficiency and sustainable materials and product selection in building. "Our ConverLight™ product provides buildings with dynamic solar and climate control, resulting to improved energy efficiency and indoor comfort. ConverLight™ also contributes to environmental certification of buildings. Buildings accounts for about a third of CO2 emissions today. We meet a lot of interest since energy efficiency and sustainability are high on the agenda in the real estate industry. The European environmental goals target that CO2 emissions shall be reduced by 20 percent by 2020, so the industry must act now," says Thomas Almesjö, CEO of ChromoGenics. "Today's tough requirements on energy efficiency, comfort as well as demand for environmental certifications have made simulation models for buildings’ performance more and more used. We help decision makers with supporting documentations for energy efficiency in buildings," says Anton Clarholm from Project Engagement. "The simulations we have performed, comparing ConverLight™ with traditional solar protections, show a significant improvement in energy performance and solar heat load in buildings while maintaining daylight," concludes Anton. "Property owners place higher demands on energy efficiency and comfort in buildings. ConverLight™ solves a problem in buildings as the market trend goes towards more glass in building. This without having to make aesthetic claims on the exterior facade," says Fredrik Bjälkensäter, Project Manager at Fasadglas in Uppsala AB, who visited Dynamic Glass Academy. "It is clear that ConverLight™ dynamic glass is right in time for a more sustainable future. We will now take the Dynamic Glass Academy event to Stockholm, Gothenburg and Malmö," concludes Thomas Almesjö, CEO of ChromoGenics. If you are interested to participate in future events, please contact info@chromogenics.com Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-10-09 Press release ChromoGenics has signed order for energy efficient smart windows to office building in Uppsala ChromoGenics AB (publ) has signed an agreement with the real estate company Saldeen Real Estate AB about providing dynamic glass for solar control to an existing office property in Uppsala. The energy-saving windows replaced the previous solar protection solution. "The office has previously had extensive problems with dazzling sun and high heat irradiation. A lot of cooling has been needed to lower the temperature, which required a lot of energy. With ChromoGenics’ energy-efficient technology, cooling needs have decreased and the indoor climate has become much more comfortable since the windows were installed. The tenants are satisfied and that makes med glad too," said Bo Saldeen, CEO of Saldeen Real Estate. Bo Saldeen previously considered investing in a larger cooling system and exterior solar protection, but the options were discarded due to that maintenance costs for awnings and similar solutions are often high, they change the appearance of the façades and daylight is deprived. “We have improved our working environment with a more comfortable climate and the dazzling sun rays are no longer a problem. In addition, we get the daylight people need and there is no longer need for curtains that shut the daylight out," says Fredrik Larsson, COO at VHD-Media, whose office is in the property. “Satisfied tenants are important to all property owners and we are pleased that our dynamic glass can contribute to it, while reducing environmental impact through lower energy consumption. Sustainability is high on the agenda for all property owners,” says Thomas Almesjö, CEO of ChromoGenics. “The order shows a need for property owners to upgrade their existing properties with energy efficient solutions. It is possible to save a lot of energy in existing properties and premises, thereby lowering carbon dioxide emissions," concludes Thomas Almesjö. ChromoGenics’ dynamic glass automatically controls heat and light emitting on premises, providing better indoor comfort and lower energy consumption. The cooling need of premises can be reduced by 20-40 percent. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-10-03 Press release ChromoGenics has appointed Åsa Stroofe as Chief Marketing Officer Regulatory information ChromoGenics is accelerating its commercialization of ConverLight™ dynamic glass for solar control given the increasing demand for energy efficiency in buildings. Åsa Stroofe has been appointed Chief Marketing Officer, CMO, from November 1st 2017 and will be part of the company’s executive management team. With a B.Sc. in Physiological Science and master classes in Marketing Management, Åsa has more than 20 years of strategic and tactical experience from both international corporations and start-ups. She has held several global marketing roles, most recently at Thermo Fisher Scientific. “We are pleased to have Åsa with us to drive our marketing strategy. Åsa brings vast experience in establishing new technologies globally,” says Thomas Almesjö, CEO of ChromoGenics. “We are now in an exciting commercialization phase and with Åsa’s customer-centric approach, we will strengthen ChromoGenics’ market position.” "I am delighted to join the energetic team at ChromoGenics,” says Åsa. "Bringing a unique sustainable solution for solar control to the real estate market is exciting. ConverLight™ dynamic glass enables property owners, architects and construction companies to decrease energy consumption and improve indoor comfort while preserving natural daylight and views. I look forward to contributing to the continued success of ChromoGenics,” concludes Åsa. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-09-27 Press release Interim report January – June 2017 Regulatory information Large order of dynamic glass to Atrium Ljungberg’s project Gränbystaden, Uppsala Second quarter of 2017 • ChromoGenics received a large order to deliver approximately 600 m2 of dynamic glass to Atrium Ljungberg’s project Gränbystaden, Uppsala. • The ConverLight™ product is generating considerable interest among real estate owners, architects energy consultants and other players in the window and façade glass market. • Net sales for the period amounted to SEK 1.7 (1.8) million. ConverLight™ is still in its initial phase of sales and production. • Net income for the period amounted to SEK -10.5 (-15.3) million, which corresponds to earnings per share of SEK -0.46 (-2.82). • The new share issue that was completed in February – March was fully registered with the Swedish Companies Registration Office on April 7, 2017. • At the annual general meeting, ChromoGenics strengthened the Board with Mari Broman and Peter Gustafson, both with background within the real estate and finance industry. 20172016 2017 2016 2016 SEK millionApr-Jun Apr-JunJan-JunJan-JunJan-DecNet sales1,71,82,81,83,0EBITDA-9,0-13,7-20,7-24,4-42,2Net income-10,5-15,3-23,8-27,6-49,5EPS after dilution, SEK-0,46-2,82-1,39-5,34-7,6Cash and cash equivalents at end of the period67,02,567,02,58,5 “Intensive period with increased production to ChromoGenics’ largest order to date and a faster tempo in the market preparation!” Comments from the CEO It has been a hectic period with production and delivery of dynamic glass to Fabege’s project Grand Central Sundbyberg. A number of our earlier delivered projects were taken into operation, including Balderskolan in Skellefteå Municipality and ICEHOTEL 365 in Jukkasjärvi. During the quarter, the largest order to date was also signed. ChromoGenics will deliver approximately 600m2 of ConverLight™ dynamic glass to Atrium Ljungberg’s project Gränbystaden, Uppsala. Atrium Ljungberg has placed both the environment and corporate responsibility high on its agenda, and selected therefore ConverLight™ because of its effective solar control solution. In June, the first Dynamic Glass Academy was held at our premises in Uppsala. An event for spreading knowledge and acceptance for the company's dynamic glass at customers and stakeholders about energy efficiency and indoor comfort in building focusing on sustainability. At the end of the same month, ChromoGenics participated in Glass Performance Days, which is one of the world’s largest forum for the glass industry. We feel that the market is showing considerable interest in our products, and I am convinced that this is just the beginning of a successful journey for ChromoGenics. Our ConverLight™ dynamic glass offers property owners, architects, energy consultants, construction companies and players in the window and façade glass industry an attractive and cost-efficient solution for solar control. ConverLight™ makes it possible to let in a reasonable amount of sunlight and heat without impairing visibility. This significantly improves the indoor climate. ConverLight™ also contributes to buildings energy efficiency by reduced electricity consumption, which is high on the environmental agenda for the sustainability work of both the EU and the commercial sector. With a strengthened Board and organization, we continue to pursue a rapid expansion by investing in sales and an efficient, reliable production capacity. The considerable interest we are meeting from various market representatives confirms that our unique technology is creating good conditions for continued successful commercialization and future profitability! Thomas Almesjö, CEO Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Market Securities Act (2007:528). The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on July 21, 2017. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com 2017-07-21 Press release ChromoGenics receives great interest in ConverLight™ during the first day of the Global Industry Forum, Glass Performance Days The largest and most important forum for the glass industry, Glass Performance Days (GPD), is scheduled this 28-30 June in Tampere, Finland. During the forum, knowledge and experiences are exchanged while the latest research results in the glass industry are presented and discussed. ChromoGenics AB (publ) participates to inform about the technology behind its patented Dynamic glass for solar control ConverLight™ and its customer benefits. On Wednesday, June 28, 2017, the doors of GPD opened, the glass industry's main forum in Finnish Tampere. The conference brings together all relevant stakeholders in the glass industry. The purpose is, inter alia, to create a platform where global networks are established and developed, experiences and research findings are exchanged as well as to enable business opportunities for the participants. "It is clear that our product is right in time. When we talk about the benefits of ConverLight™ for players in the growing market of construction projects that demand increased flexibility, design freedom combined with cost and energy efficiency, we get a very positive response," says Greger Gregard, CTO at ChromoGenics. ChromoGenics participates in GPD to spread insight about the benefits of the company's patented technology for dynamic glass, ConverLight™. During the first day of GDP, a great deal of interest has been shown for the dynamic solar control system, which has a number of advantages for both the indoor climate and the environment. "This is a very good opportunity for us to introduce our unique technology. There have already been several interesting meetings and it is exciting to be part of an industry where an optimistic future is seen by all participants. We take the opportunity to establish new and deepen existing relationships with relevant decision makers and business partners," concludes Thomas Almesjö, CEO of ChromoGenics. About GPD Glass Performance Days (GPD) is a forum for the development of the global glass industry through exchange of knowledge. This is done by organizing conferences in different countries. At present, the conferences are held in Finland, China and Brazil every second year. In Finland, GPD also organizes workshops and a glass exhibition. The GPD celebrates its 25th anniversary this year in Finnish Tampere on 28-30 June 2017. https://gpd.fi/events/gpd-finland-2017/ Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-06-30 Press release ChromoGenics’ dynamic glass technology meets the midnight sun on ICEHOTEL 365 in Jukkasjärvi When the ICEHOTEL 365 opened in spring 2017, the building had a beautiful window installed with the dynamic glass technology ConverLight™. The collaboration between ChromoGenics AB (publ) and ICEHOTEL 365 now contributes positively to the visitors' experience and ICHOTEL's goal of working in harmony with nature. In Jukkasjärvi the sun shines for 100 days in a row during the summer months. ICEHOTEL has installed a solar system to take care of the almost constant daylight during these months. It provides an energy surplus that is used to drive the other buildings, such as restaurants, offices and warm rooms. But there is also a great potential for increased energy efficiency in allowing sunlight inside without the sun's heat coming in. ConverLight™ is a flexible and dynamic glass solution where effective solar control provides increased indoor comfort and lower energy consumption, while at the same time the person in the room has a natural contact with the outside world. "Now that our guests can combine their ice experience with art and activities all year round, it becomes even more important for us to find new and innovative solutions on our way to becoming CO2-negative. ChromoGenics’ innovative glass technology ConverLight™ shows great potential for being the perfect solution for us who want to optimize our guests' experience while increasing our energy efficiency," declares Yngve Bergqvist founder and initiator of Icehotel. ICEHOTEL is situated in a natural area, right on the river Torne - Sweden's northernmost and largest national river. Nature is an important part of the business, a source of inspiration, experiences and, not least, building materials. In the new building, which was opened this year, a beautiful window has been installed with ChromoGenics’ dynamic glass technology. Energy savings are achieved by reducing cooling requirements in the room as the excess solar radiation can be effectively reduced with dynamic toning in the glass. With ConverLight™, the impact on the environment is reduced while allowing people’s well-being and to feel comfortable. "We are proud that our dynamic glass technology ConverLight™ has been installed at the ICEHOTEL 365. Their efforts mean that, as of this year, visitors can enjoy the unique combination of ice-sculptures and outstanding natural experiences throughout the year - even though the midnight sun still belongs to the summer months. We look forward to being able to continue contributing to ICEHOTEL's unique operations and important environmental work at all levels," says Thomas Almesjö, CEO of ChromoGenics. About ICEHOTEL ICEHOTEL is the world’s first hotel made of ice and snow. Founded in 1989, it is reborn in a new guise every winter, in the Swedish village of Jukkasjärvi – 200 km north of the Arctic Circle. The Torne River, the arts, and creating a setting for life-enriching moments are at the heart of it all. The ICEHOTEL 365, presented this year, is a brand new ice experience that can be visited all year round. ICEHOTEL is a multiple winner of the World Travel Awards and has about 50,000 visitors a year. www.icehotel.com Contact: Josefin Lindberg, Media & PR, ICEHOTEL Tel: +46 (0)73 923 2725 E-mail: info@icehotel.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com Contact: Thomas Almesjö, CEO, ChromoGenics ABSusanne Andersson, CFO & Head of Communications , ChromoGenics ABTel: +46 18 430 0430 E-mail: info@chromogenics.com 2017-06-26 Press release Skellefteå municipality is investing in energy saving and has chosen ChromoGenics’ dynamic glass for Baldergymnasiet in Skellefteå ChromoGenics AB (publ) has completed commissioning of ConverLight™ dynamic glass at Baldergymnasiet in Skellefteå. Skellefteå municipality is early on with new technology for sustainable construction, with better energy saving and indoor comfort. The project was started in 2016. ChromoGenics signed an agreement in 2016 to deliver ConverLight™ dynamic glass to Baldergymnasiet in Skellefteå. The project included both a renovation and an expansion project. ConverLight™ provides buildings with efficiently regulated solar control, which contributes to improved energy efficiency and indoor comfort as well as providing added value for environmental certification of real estate. "We are proud to be part of this project focusing on environment and sustainability," initiates Thomas Almesjö, CEO of ChromoGenics. "Our product ConverLight™ controls heat and light emitting while maintaining daylight and full view to the outside world. This results in energy savings and increases the comfort and well-being of people staying in the building. In addition, ConverLight™ contributes to lower maintenance costs as well as environmental certification of buildings, which is high on today's agenda to achieve European environmental goals to reduce CO2 emissions by 20 percent by 2020. It is inspiring that Skellefteå municipality is at an early stage with a clear agenda for a more sustainable future," concludes Thomas Almesjö. "We want to offer students and teachers modern and attractive premises to stay in. ConverLight™ dynamic glass was chosen to secure energy savings, and to prevent any investment in air conditioning system for the building. ConverLight™ contributes to enhanced indoor comfort, thus improving the efficiency and work environment for students and teachers. During the winter months, ConverLight™ can be configured to allow daylight and heat radiation from the sun. Furthermore, we estimate that ConverLight™ dynamic glass will reduce our maintenance costs compared to the exterior fixed awnings we used to have," says Robin Söderlund, Property Manager, Support and Facilities, Skellefteå Municipality. "We are committed to a sustainable future where strategic technology choices such as ConverLight™ enable significant progresses. This is part of a larger EU project, RESSEPE, within energy efficiency that is taking place in our municipality," concludes Gustaf Ulander, Coordinator International Unit, Skellefteå Municipality. For more information see the video: Baldergymnasiet in Skelleftea municipality Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. About the municipality of Skellefteå Skellefteå grows. The cityscape changes every day with new bodies moving up and drawing new lines in the Skellefteå silhouette. Business, private individuals, public authorities and municipalities help to contribute to the largest building boom we have experienced in Skellefteå for over 20 years. All in line with our efforts to be 80,000 inhabitants in 2030. Part of the development is also to change and adapt existing buildings to new ways of use as well as new technologies. Baldergymnasiet has undergone a major renovation and expansion as part of the upper secondary school in Skellefteå. www.skelleftea.se About the project RESSEEPE The project is funded by the EU's Seventh Framework Program, in the field of energy-efficient buildings. The purpose is to show new ways to make existing public buildings more energy efficient, both through planning efforts and using new technologies. At Baldergymnasiet, new insulation techniques, dynamic glass and energy-saving LED lighting are used. In the international project RESSEEPE, 25 partners in 10 different countries have collaborated, and efforts are being made in three locations in Europe - Skellefteå, Coventry and Barcelona. http://www.resseepe-project.eu Contact: Gustaf Ulander, Coordinator International Unit, Skellefteå Municipality Tel: +46 70 238 4640 E-mail: gustaf.ulander@skelleftea.se 2017-06-20 Press release ChromoGenics has appointed Mats Wahl as Production Development Manager ChromoGenics AB (publ)) sees growing demand for ConverLight™ dynamic glass for solar control and increases production volumes. Mats Wahl has been appointed Production Development Manager. Mats adds extensive technical industrial expertise to ChromoGenics. Mats has had technical operational roles in which he successfully developed and implemented cost-effective production processes as well as introduced lean concepts to ensure efficient and quality-assured production. Mats comes from Munters Europe AB, Uppsala, where he worked as Production Manager. "We are very pleased to have Mats with us to ensure high-yield production processes. Mats has a deep industrial background focusing on quality and efficiency throughout the production process to installation at the customer, says Micael Hamberg, COO for ChromoGenics. "We are in an exciting growth phase. With Mats' extensive experience, he will together with the supply chain organisation drive technical processes in line with increasing volumes to ensure a high quality delivery precision to our customers." "I look forward to contributing to ChromoGenics’ processes within the supply chain," says Mats Wahl. "ConverLight™ Dynamic Glass for solar control is an interesting product of the time with high value for sustainability. It is exciting to participate in and contribute to the growth journey and ensure cost-effective production processes for larger volumes, "summarizes Mats. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-06-08 Press release Great interest in ChromoGenics' seminar focusing on sustainability ChromoGenics AB (publ) welcomed guests from the real estate industry to Dynamic Glass Academy today, a seminar on energy efficiency and comfort in buildings focusing on sustainability. ChromoGenics invited a number of customers and stakeholders from the real estate industry to Dynamic Glass Academy, a recurring seminar aimed at learning and sharing experiences about trends in energy efficiency and comfort in buildings, and how to make related procurements of components and building systems as efficient as possible. A number of guest speakers presented the latest in sustainability trends, energy efficiency and climate control in buildings and public procurements of cleantech. The event ended with a tour of the high-tech production plant for ConverLight™ dynamic glass. "Our ConverLight™ product provides buildings with dynamic solar- and climate control, which results to improved energy efficiency and indoor comfort. ConverLight™ also contributes to environmental certification of buildings, which is high on today's agenda to achieve the European environmental goals to reduce CO2 emissions by 20 percent by 2020. With our seminar today we want to spread information about related aspects to consider and learn from each other about sustainability," says Thomas Almesjö. "It was valuable to attend this seminar since increased energy efficiency and indoor comfort are totally right in time, especially when the market trend goes towards more glass in buildings. It will be interesting to follow ChromoGenics’ development," says Mikael Rhodin, Prescription Sales Manager at Sapa Building Systems, who visited Dynamic Glass Academy at ChromoGenics. "It is encouraging to see such enthusiasm among architects, real estate companies, energy consultants and other stakeholders here today. It is clear that ConverLight™ dynamic glass is right in time for a more sustainable future, "concludes Thomas Almesjö, CEO of ChromoGenics. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-06-01 Press release ChromoGenics has appointed Björne Ekberg as procurement and logistics manager ChromoGenics AB (publ) sees the growing demand for ConverLight ™ dynamic glass for solar control and increases production volumes. Björne Ekberg has been appointed Procurement and Logistics Manager. Björne brings extensive experience from growth companies and industrial expertise to ChromoGenics. Björne has had strategic and operational roles in which he has successfully managed and developed relationships with subcontractors to ensure an efficient and quality assured supply of goods in international environments. Björne comes from Gyros, Uppsala, where he worked as a supply chain manager. "We are very pleased to have Björne with us to take our procurement and logistics function to the next level. Björne has a long and broad industrial background focusing on quality throughout the supply flow for optimized customer and supplier relationships, "says Micael Hamberg, COO for ChromoGenics. "We are in an exciting growth phase. With Björne's extensive experience, he will handle subcontractors agreements in line with increasing volumes as well as ensure a delivery precision with high quality to our customers. " "I look forward to contribute to ChromoGenic's growth journey," says Björne Ekberg. "ConverLight ™ dynamic glass for solar control is a product in time with a high value for sustainability. It is exciting that interest in the product is increasing and I look forward to ensure deliveries with satisfied customers as a focus, "concludes Björne. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-05-16 Press release ChromoGenics strengthens the board with new members ChromoGenics AB (publ) strengthens the board with Mari Broman and Peter Gustafson, both with a background in the real estate and finance industry. They were elected to the Board at the company's AGM on May 10, 2017. "We welcome Mari and Peter to the Board. Now ChromoGenics is on the stock exchange and has begun the commercialization phase, which places new demands on the company. With Mari and Peter, expertise is being provided in both the real estate and finance industry, which will contribute positively to future conditions for growth and development, "says Anders Brännström, Chairman of the Board ChromoGenics. Mari Broman has extensive experience in the construction and real estate industry and has had senior positions and board assignments in both the public sector and private industry. "I look forward to contributing to the continued development of ChromoGenics. It is an exciting company with an interesting product right in the time when there is a high focus on sustainability and energy savings within the real estate industry, "says Mari Broman. Peter Gustafson has long and wide experience in corporate finance, investment advice and business development in construction, property and infrastructure, as well as energy and energy technology. "It will be exciting to take ChromoGenics to the next level in the growth phase. There is a great interest in ChromoGenics’ product and market analyzes show strong growth in the coming year. I look forward to being part of and contributing to the company's growth journey, "concludes Peter. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-05-11 Press release Annual General Meeting 2017 in ChromoGenics AB (publ) Regulatory information ChromoGenics AB (publ) held its Annual General Meeting May 10th 2017 in Uppsala. Annual Report and Results The Annual General Meeting adopted the profit and loss statement and the balance sheet for the financial year 2016 and decided, in accordance with the Board's proposal, that the accumulated loss of a total of SEK 38,902,527 was carried forward in new account. It was further resolved that no dividend was to be paid. Discharge The Annual General Meeting discharged the Board members and the Managing Director from liability for the financial year 2016. Board and auditor's fees It was resolved to pay to each board member who is not i) employed by the company, ii) founder or main owner of the company, or iii) appointed by or a connected person to founder or main owner of the company, with SEK 100,000 for ordinary board members, and SEK 150,000 for the chairman. It was decided that remuneration to the auditor should be paid on an open account basis. Election of Board and Auditor As part of strengthening the company's expertise, Peter Gustafson and Mari Broman were elected new directors of the Board. Anders Brännström, Claes-Göran Granqvist, Jerker Lundgren and Poul Erik Schou-Pedersen were re-elected as directors. Decision on election committee The Annual General Meeting resolved that the Company, in advance of the next general meeting to be held in 2018, shall establish a nomination committee. The chairman will instruct the three shareholders with the largest holdings of shares/votes in the Company to appoint a representative each that together with the chairman shall constitute the nomination committee. Share issue authorization The Annual General Meeting resolved to authorize the Board, on one or more occasions until the next annual general meeting, to issue shares, warrants and / or convertibles. with or without deviation from the shareholders' pre-emption rights and/or an issue in kind, an issue by way of set-off or any other conditions. The authorization can be used to issue maximum 2 321 432 shares, which corresponds to approximately 10 per cent of the outstanding number of shares. ChromoGenics AB (publ) Uppsala, May 10, 2017 The Board Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the Market Securities Act (2007:528) and/or to the Act (1991:980) regarding trading with financial instruments. The information was submitted for publication, through the agency of the contact person set out above, at 16:00 CET on May 10, 2017. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-05-10 Press release Interim report January – March 2017 Regulatory information Prestige order for Fabege’s project Grand Central Sundyberg First quarter of 2017 ChromoGenics received a large order to deliver approximately 550m2 of dynamic glass to real estate company Fabege’s project Grand Central Sundyberg in Stockholm. Revenue amounted to SEK 1.0 (0.0) million. The ConverLight™ product is generating considerable interest among property owners, architects and other companies in the flat glass market. The net income amounted to SEK -13.3 (-12.3) million, corresponding to SEK -1.21 (-2.51) per share. Cash and cash equivalents at the end of the period amounted to SEK 82.5 (10.6) million. ChromoGenic’s new share issue was oversubscribed and contributed SEK 117.3 million to the company. In conjunction with the new share issue, the company obtained more than 2,000 new shareholders at the same time as the number of outstanding shares increased from 9,414,326 to 23,214,326. On March 23, 2017, trading of the shares and warrants began on Nasdaq First North Stockholm. Important events after the end of the period ChromoGenics announced on April 27, 2017, another prestige order to deliver approximately 600m2 of dynamic glass to Atrium Ljungberg’s project Gränbystaden in Uppsala. The new share issue was registered with the Swedish Companies Registration Office on April 7, 2017 “The new year has really started with a bang - a completed IPO followed by two large orders! Respectively the largest orders to date for ChromoGenics!” Comments from the CEO There was a great interest to subscribe shares in our company in combination with our initial public offering. We will work hard to create long-term value for both our customers and our shareholders as well as other stakeholders through a full-scale launch of our dynamic glass. Our glass makes properties more attractive by improving energy efficiency and indoor comfort. During the first quarter and immediately after, we presented our two largest commercial orders to date. ChromoGenics will deliver approximately 550m2 of ConverLight™ dynamic glass to Fabege’s project Grand Central Sundbyberg, which will be certified in accordance with the world’s most established certification system for sustainable buildings. Our dynamic glass was selected for its flexible design and advantages with regard to energy efficiency and indoor comfort. Production is in full swing and delivery will occur during the first half of 2017. We will also deliver approximately 600m2 of ConverLight™ dynamic glass to Atrium Ljungberg’s project Gränbystaden in Uppsala. This order is part of the expansion of the mall, which is expected to begin during the second half of 2017 and be completed in time for the 2018 Christmas shopping season. Atrium Ljungberg has placed both the environment and sustainability high on its agenda, and the company has selected ConverLight™ because of the glass’s effective solar protection. We feel that the market is showing considerable interest in our products, and I am convinced that this is just the beginning of a successful journey for ChromoGenics. Our dynamic ConverLight™ glass offers property owners, architects, construction companies and participants in the glass industry cost-efficient solar control. ConverLight™ makes it possible to let in a reasonable amount of sunlight and heat without impairing visibility. This significantly improves the indoor climate. ConverLight™ also helps lower a property’s consumption of electricity, which is high on the environmental agenda for the sustainability work of both the EU and the commercial sector. A well-respected US analysis firm, n-tech Research, has forecast that the market for dynamic glass will increase dramatically over the next decade. ChromoGenics finds itself in a very interesting position in that the company is facing good conditions to establish itself as a leader in the market. We will now focus our resources on a rapid expansion by continuing to invest in sales and production, thus creating good conditions for continued commercialization and future profitability! Thomas Almesjö, CEO Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Market Securities Act (2007:528). The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on April 28, 2017. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-04-28 Press release ChromoGenics receives a larger order to deliver approximately 600m2 of dynamic glass to Atrium Ljungberg's project in Gränbystaden, Uppsala Regulatory information ChromoGenics AB (publ) has been selected to supply, with the facade contractor Fasadglas AB, approximately 600m2 of dynamic glass to Atrium Ljungberg’s project in Gränbystaden, Uppsala. The order includes expanding the mall where ChromoGenic's dynamic glass contributes with increased energy efficiency and indoor comfort. ChromoGenics will deliver ConverLight™ dynamic glass to some of the projects in Gränbystaden in Uppsala. The order includes expansion of the mall, which is expected to begin in the second half of 2017 and to be completed before the Christmas trade in 2018. ConverLight™ provides buildings with effective solar control, which contributes to improved energy efficiency and indoor comfort as well as add value to environmental certification of real estate. "We are proud to be part of this project focusing on sustainable buildings," commences Thomas Almesjö, CEO of ChromoGenics. "Our product ConverLight™ controls heat and light transmission while maintaining daylight and full view to the outside world. This results in energy savings and increases the comfort and well-being of people staying in the building. In addition, ConverLight™ contributes to lower operating costs and environmental certification of buildings, which is high on today's agenda to achieve European environmental goals to reduce CO2 emissions by 20 percent by 2020, "concludes Thomas Almesjö. "In Gränbystaden we want to create Uppsala's second city center by continuing to build city qualities and develop the area with a mix of business trade, offices and housing, as well as service and cultural activities. Our properties are to be attractive and modern with high energy efficiency", initiates Michael Neumann, Project manager at Atrium Ljungberg. "ConverLight™ dynamic glass was chosen for its flexible design and the benefits of energy efficiency and indoor comfort. This is a very good solar control solution because environment and sustainability are high on our agenda, "concludes Michael Neumann, Atrium Ljungberg. "Our aim is to be the first to offer our customers the latest and most suitable innovations in the glass industry, where sustainable construction and energy efficiency are in focus. With ConverLight™ we offer dynamic solar control for increased energy savings and indoor comfort without having to make aesthetic claims on the exterior facade, "says Linus Moëll at Fasadglas in Uppsala AB. "We think it is really exciting to be one of the first in Sweden to offer dynamic glass that contributes positively to the environmental goals," concludes Linus Moëll. More information about projects Gränbystaden, Uppsala: http://al.se/omraden/uppsala/granbystaden/ Contact:Thomas Almesjö, CEOSusanne Andersson, CFO & Head of CommunicationsTel: +46 18 430 0430E-mail: info@chromogenics.comThis information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on April 27, 2017. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenicsChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com About Atrium LjungbergAtrium Ljungberg is one of Sweden's biggest listed property companies. We are located in growth markets in Stockholm, Gothenburg, Malmö and Uppsala. Our focus is on owning, developing and managing primarily retail and office property In order to create exciting urban environments that are sustainable in the long run, attractive over time and have space for education, culture, services and housing. The total letting area is over one million square meters, distributed among around fifty properties and valued at SEK 39 billion. The retail hubs draw 60 million customers and visitors on an annual basis and the areas include more than 30,000 workers and students as well as 1,000 residents. Atrium Ljungberg is listed on the NASDAQ Stockholm Large Cap list. www.al.se Contact:Michael Neumann, Project manager Atrium LjungbergTel: +46 70 927 60 95E-mail: michael.neumann@al.se About Fasadglas ABFasadglas was founded in 1913, and is one of the oldest companies in glass and metal work. Over the years, the craft has gone hand in hand with the search for new solutions and systems. Therefore, today we are a glass constructor who master the entire chain. From innovation and dimensioning, to construction and construction. www.fasadglas.se Contact:Linus Moëll, Fasadglas i Uppsala ABTel: +46 (0) 18 13 76 08E-mail: linus.moell@fasadglas.se 2017-04-27 Press release ChromoGenics sees increasing market demand and has appointed Mats Hellman as Head of Business Development ChromoGenics is accelerating its business and partner relationships given the increasing market demand for ConverLight™ dynamic glass and solar control. Mats Hellman has been appointed Head of Business Development. Mats brings vast experience from fast growing businesses and industrial expertise to ChromoGenics. Mats has held several Vice President and General Management positions in Sweden and internationally establishing, driving and developing global businesses in multi culture environments. “We are pleased to have Mats with us to drive our business development. Mats is entrepreneurial and has a long, broad and successful industrial experience, says Thomas Almesjö, CEO of ChromoGenics. “We are now in an exciting commercialization phase and with Mats and his extensive experience, we will accelerate our development of the business to new levels, including strategic partnerships, to strengthen ChromoGenics’ market position.” ChromoGenics is currently ramping up production to meet the rapidly increasing market demand for ConverLight™ dynamic glass. The strengthened business development function will primarily reinforce the company’s sales and marketing activities. "I'm excited to join ChromoGenics” says Mats. "ConverLight™ dynamic glass with its solar control is bringing significant sustainable value to buildings worldwide given the need for optimized energy efficiency and indoor comfort. I look forward to contribute to the future success of ChromoGenics, concludes Mats." Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-04-25 Press release Notice of stabilization measures in ChromoGenics during the period 23 March to 21 April 2017 on Nasdaq First North, Stockholm Regulatory information NOT FOR DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, TO NEW DISTRIBUTORS IN THE UNITED STATES OR FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR RELEASE WOULD BE ILLEGAL BY APPLICABLE LAW ChromoGenics AB (publ) announces that stabilizing trading by Erik Penser AB ("EPB") in ChromoGenics’ shares on Nasdaq First North, Stockholm has ended. The stabilization period in connection with the listing of the shares in ChromoGenics AB on Nasdaq First North Stockholm commenced on March 23, 2017 and ended on April 21, 2017. During the period, stabilization acquisitions totaled 121,312 shares. The stabilization period is completed and no further stabilization transactions will be implemented. EPB, acting as stabilization firm, has announced that stabilization trading has been carried out, in accordance with Article 5 (4) of the EU Market Use Regulation 596/2014, on Nasdaq Stockholm as follows: Stabilizing Information: Issuer: ChromoGenics AB (publ) Instrument: Stocks (ISIN SE0009496268) Outcome of the Offer: 13,921,312 shares, of which stabilization max 121 312 shares Offer Price: 8.50 SEK per share Ticker: CHRO Stabilization firm: Erik Penser Bank AB (publ) Stabilizing Trading Price Price Price Date Quantity (highest) (lowest) (average) Currency Market place 2017-03-23 85 500 8,20 6,30 6,71 SEK Nasdaq First North 2017-03-24 2 000 6,20 6,20 6,20 SEK Nasdaq First North 2017-03-27 12 000 6,80 6,30 6,60 SEK Nasdaq First North 2017-03-28 5 000 6,50 6,35 6,44 SEK Nasdaq First North 2017-03-29 812 6,55 6,40 6,46 SEK Nasdaq First North 2017-03-30 - - - - - - 2017-03-31 - - - - - - 2017-04-03 - - - - - - 2017-04-04 - - - - - - 2017-04-05 2 000 7,20 7,20 7,20 SEK Nasdaq First North 2017-04-06 - - - - - - 2017-04-07 4 000 7,35 7,25 7,30 SEK Nasdaq First North 2017-04-10 1 000 7,25 7,25 7,25 SEK Nasdaq First North 2017-04-11 9 000 7,40 7,30 7,34 SEK Nasdaq First North 2017-04-12 - - - - - - 2017-04-13 - - - - - - 2017-04-18 - - - - - - 2017-04-19 - - - - - - 2017-04-20 - - - - - - 2017-04-21 - - - - - - G&W Fondkommission is the financial advisor to ChromoGenics in connection with the transaction and appointed as Certified Adviser. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and according to the Act (1991:980) regarding trading with financial instruments. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on April 24, 2017. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. Important information Publication and distribution of this announcement may in certain jurisdictions be restricted by law and persons in those jurisdictions where this press release has been published or distributed should inform themselves about and observe such restrictions. The information in this press release is not an offer to purchase, subscribe for or otherwise trade in shares or other securities in ChromoGenics. This press release is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Singapore, South Africa or other country where such action would require additional measures in addition to those following Swedish law or where this would contravene the laws or regulations of that country. The information in this press release may not be forwarded, reproduced or disclosed in ways that conflict with such restrictions. Failure to comply with this instruction may result in violation of the United States Securities Act of 1933 (the "Securities Act") as amended, or applicable laws in other jurisdictions. 2017-04-24 Press release ChromoGenics notice to Annual General Meeting Regulatory information Shareholders in ChromoGenics AB (publ) are hereby invited to the Annual General Meeting Wednesday May 10 2017 at 14.00 CET at the offices of Law firm Lindahl, Vaksalagatan 10, Uppsala. NOTICE OF ANNUAL GENERAL MEETING IN CHROMOGENICS AB (PUBL) The shareholders in ChromoGenics AB (publ) reg. no. 556630-1809 (the “Company”) are hereby convened to the annual general meeting on Wednesday May 10, 2017, at 14.00 at the offices of Law firm Lindahl, Vaksalagatan 10, 751 42 Uppsala. Notice etc. Shareholders who wish to participate at the annual general meeting must: - on Thursday May 4, 2017, be registered in the share register kept by Euroclear Sweden AB, and - notify his or her intention to attend the general meeting by mail to Ullforsgatan 15, 752 28 Uppsala, stating “annual general meeting”, by telephone to 018-43 00 430, or by e-mail to info@chromogenics.com, at the latest on Monday May 8, 2017. Such notification shall include the shareholder’s name, personal identification number or corporate registration number (or similar), address and daytime telephone number, number of shares, details on advisors (no more than two), if any, and where applicable, details of representatives or proxies. Nominee-registered shares To be entitled to participate in the general meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own names in the share register maintained by Euroclear Sweden AB in order to be entitled to attend the general meeting. Such registration must be duly effected in the share register on Thursday May 4, 2017, and the shareholders must therefore advise their nominees well in advance of such date. Shareholders who have not executed such re-registration will not be entitled to participate in the general meeting. Proxy Shareholders represented by proxy must submit a dated power of attorney. If the power of attorney is executed by a legal person, a certified copy of the certificate of registration or equivalent must be attached. The power of attorney may not be valid for a period longer than five years from its issuance. The original power of attorney and certificate of registration should be submitted to the Company by post at the address mentioned above in due time prior to the general meeting. The Company provides a form of power of attorney at request and it is also available at the Company’s website, www.chromogenics.com/sv. Number of shares and votes As of the date of this notice, there are a total of 23 214 326 shares and votes in the Company. Proposed agenda 1. Opening of the general meeting and election of chairman of the general meeting 2. Preparation and approval of the voting list 3. Approval of the agenda 4. Election of one or two persons to verify the minutes 5. Determination as to whether the meeting has been duly convened 6. Presentation of the annual report and the auditor’s report 7. Resolutions on: a) the adoption of the income statement and the balance sheet, b) allocation of the Company’s loss according to the adopted balance sheet, and c) discharge from liability for each of the members of the board of directors and the managing director 8. Resolution on the number of members of the board of directors, deputy members of the board of directors, auditors, and deputy auditors 9. Determination of remuneration to the board of directors and the auditor 10. Election of members of the board of directors, deputy members of the board of directors, if any, and auditor 11. Resolution on the nomination committee for the next annual general meeting 12. Resolution to authorize the board of directors to issue new shares, warrants and/or convertible instruments 13. Closing of the general meeting Proposals to resolutions Item 1 – Election of chairman of the general meeting It is proposed that Mattias Prage, Law firm Lindahl, is elected as chairman of the general meeting. Item 6b) – Allocation of the Company’s results according to the adopted balance sheet The board of directors propose that no dividends will be paid for the year 2016 and that the accumulated loss of SEK 38 190 527 is carried forward into new account. Item 8 – Resolution on the number of members of the board of directors and deputy members of the board of directors Shareholders representing approx. 41 per cent of the shares/votes of the Company have proposed that the board of directors until the end of the general meeting shall consist of six (6) directors. Furthermore it is proposed that the Company shall elect a registered accounting firm as its auditor. Item 9 – Determination of remuneration to the board of directors and the auditor Shareholders representing approx. 41 per cent of the shares/votes of the Company have proposed that remuneration is paid to each board member who is not i) employed by the company, ii) founder or main owner of the company, or iii) appointed by or a connected person to founder or main owner of the company, with SEK 100.000 for ordinary board members, and SEK 150.000 for the chairman. Item 10 – Election of members of the board of directors, chairman of the board of directors and deputy members of the board of directors, if any Shareholders representing approx. 41 per cent of the shares/votes of the Company have proposed re-election of Anders Brännström as chairman of the board, Poul-Erik Schou Pedersen, Claes-Göran Granqvist and Jerker Lundgren as directors and election of Peter Gustafson and Mari Broman as directors. Peter Gustafson has extensive experience from corporate finance, investment advisory and business development. Peter has held senior positions in companies such as Catella, Arthur Andersen, Deloitte, HSH Nordbank and Ice Capital. Peter has experience and knowledge from several business areas such as banking, finance, professional services, knowledge-based companies, construction, real estate, infrastructure, energy and energy technology. Mari Broman has extensive experience from the construction and real estate business and has held senior positions both within public administration and private sector. She has been deputy city manager in Gothenburg and deputy managing director at Riksbyggen and has experience from work with the board of directors from AF-gruppen and Serneke Group AB. Furthermore Mari has experience as chairwoman within certain program council at the Swedish Energy Agency (Sw. Energimyndigheten) and member of the board for Sweden Green Building Council. It is proposed that PriceWaterhouseCoopers (PwC) is appointed as auditor of the Company, with Leonard Daun as chief auditor, until the annual general meeting to be held in 2018. Item 11 – Resolution on the nomination committee for the next annual general meeting The board of directors propose that the general meeting resolve that the Company, in advance of the next general meeting to be held in 2018, shall establish a nomination committee. It is proposed that the chairman shall instruct the three shareholders with the largest holdings of shares/votes in the Company to each appoint a representative that together with the chairman shall constitute the nomination committee. If any of these three shareholders abstain from its/his/her right to appoint a representative the right passes on to the shareholder that, besides those shareholders that have already abstained or appointed a representative, owns the most shares/votes . It is proposed that the nomination committee shall be tasked with the duty to, at the next general meeting to be held in 2018, bring forward propositions on: • election of the board of directors • election of the chairman • remuneration to the board of directors • election of auditor • remuneration to the auditor • chairman at the general meeting • guidelines for election to the nomination committee Item 12 – Resolution on the authorization of the board of directors to resolve on the issue of new shares/convertibles/warrants The board of directors propose that the shareholders’ meeting authorizes the board of directors, for the time until the next annual general meeting, to issue shares, warrants and/or convertibles. This may be done at one or several occasions and with or without deviation from the shareholders' pre-emption rights and/or an issue in kind, an issue by way of set-off or any other conditions. An issue in accordance with this authorization shall be on market conditions. The board of directors shall be authorized to decide on the terms and conditions regarding issues under this authorization and what persons shall be entitled to subscribe for the shares, warrants and/or convertible instruments. The reason to propose that the board of directors shall be authorized to resolve on an issue with deviation from the shareholders’ pre-emption rights and that the board shall be authorized to decide on an issue in kind or an issue by way of set-off or otherwise on such terms and conditions as referred to above is in connection with acquisitions of companies or businesses, participate in strategic partnerships and to carry-out directed new issues in order to raise capital to the company. The number of shares that could be issued due to this authorization shall not exceed 2 321 432, corresponding to approximately 10 per cent of the current outstanding number of shares. It is proposed that the managing director is authorized to make such minor adjustments to this resolution that may be necessary in connection with the registration with the Swedish Companies Registration Office and Euroclear Sweden AB. A resolution in accordance with the proposal to authorize the board of directors is valid only if supported by shareholders holding at least two-thirds of both the votes cast and the shares represented at the meeting. Information at the Annual General Meeting The board of directors and the president shall, upon request by any shareholder and where the board of directors determines that it can be done without material harm to the Company, provide information of circumstances which may affect the assessment of a matter on the agenda, and circumstances which may affect the assessment of the Company’s financial position. Documentation The annual report and the auditor’s report, the auditor’s report regarding compliance with the guidelines for remuneration to the senior as well as other documents according to the Swedish Companies Act will be held available at the Company’s office with address Ullforsgatan 15, Uppsala, not later than three weeks before the meeting, i.e. not later than April 19, 2017,. The documents will also be sent, without charge, to shareholders who so request and inform the Company of their postal address. The documents will also be available and presented at the general meeting. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. Uppsala in April 2017 ChromoGenics AB (publ) The board of directors Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 2017-04-12 Press release Notice of stabilization measures in ChromoGenics during the period 3 – 11 April 2017 on Nasdaq First North, Stockholm Regulatory information NOT FOR DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, TO NEW DISTRIBUTORS IN THE UNITED STATES OR FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR RELEASE WOULD BE ILLEGAL BY APPLICABLE LAW ChromoGenics AB (publ) announces that stabilizing trading have been carried out by Erik Penser AB ("EPB") in ChromoGenics’ shares on Nasdaq First North, Stockholm. As announced in connection with the offer for subscription of new shares in ChromoGenics and listing of company’s shares on Nasdaq First North, Stockholm (the "Offer"), EPB has the option, as stabilization firm, to perform trading in order to support the market price of the shares at a higher level than would otherwise have been prevailing in the market. Stabilization transactions may be carried on Nasdaq First North, Stockholm, the OTC market or otherwise, at any time during the period beginning on the first day of trading of the shares on the Nasdaq First North, Stockholm, and end no later than 30 calendar days thereafter. EPB has no obligation to perform any stabilization and there is no guarantee that stabilization will be undertaken. If stabilization is started, it can also be terminated at any time without notice. Under no circumstances will the transaction be carried out in order to support the market price of the shares at the price higher than the price in the Offer. EPB, acting as stabilization firm, has announced that stabilization trading has been carried out, in accordance with Article 5 (4) of the European Market Abuse Regulation 596/2014, on Nasdaq First North Stockholm as per below. Contact at EPB is Anders Kappling, tel: +46 8 463 80 00 Stabilizing Information: Issuer: ChromoGenics AB (publ) Instrument: Stocks (ISIN SE0009496268) Outcome of the Offer: 13,921,312 shares, of which stabilization max 121 312 shares Offer Price: 8.50 SEK per share Ticker: CHRO Stabilization firm: Erik Penser Bank AB (publ) Stabilizing Trading Price Price Price Date Quantity (highest) (lowest) (average) Currency Market place 2017-04-03 - - - - - - 2017-04-04 - - - - - - 2017-04-05 2 000 7,20 7,20 7,20 SEK Nasdaq First North 2017-04-06 - - - - - - 2017-04-07 4 000 7,35 7,25 7,30 SEK Nasdaq First North 2017-04-10 1 000 7,25 7,25 7,25 SEK Nasdaq First North 2017-04-11 9 000 7,40 7,30 7,34 SEK Nasdaq First North G&W Fondkommission is the financial advisor to ChromoGenics in connection with the transaction and appointed as Certified Adviser. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and according to the Act (1991:980) regarding trading with financial instruments. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on April 12, 2017. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. Important information Publication and distribution of this announcement may in certain jurisdictions be restricted by law and persons in those jurisdictions where this press release has been published or distributed should inform themselves about and observe such restrictions. The information in this press release is not an offer to purchase, subscribe for or otherwise trade in shares or other securities in ChromoGenics. This press release is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Singapore, South Africa or other country where such action would require additional measures in addition to those following Swedish law or where this would contravene the laws or regulations of that country. The information in this press release may not be forwarded, reproduced or disclosed in ways that conflict with such restrictions. Failure to comply with this instruction may result in violation of the United States Securities Act of 1933 (the "Securities Act") as amended, or applicable laws in other jurisdictions. 2017-04-12 Press release Notice of stabilization measures in ChromoGenics during the period 23 – 31 March 2017 on Nasdaq First North, Stockholm Regulatory information NOT FOR DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, TO NEW DISTRIBUTORS IN THE UNITED STATES OR FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR RELEASE WOULD BE ILLEGAL BY APPLICABLE LAW ChromoGenics AB (publ) announces that stabilizing trading have been carried out by Erik Penser AB ("EPB") in ChromoGenics’ shares on Nasdaq First North, Stockholm. As announced in connection with the offer for subscription of new shares in ChromoGenics and listing of company’s shares on Nasdaq First North, Stockholm (the "Offer"), EPB has the option, as stabilization firm, to perform trading in order to support the market price of the shares at a higher level than would otherwise have been prevailing in the market. Stabilization transactions may be carried on Nasdaq First North, Stockholm, the OTC market or otherwise, at any time during the period beginning on the first day of trading of the shares on the Nasdaq First North, Stockholm, and end no later than 30 calendar days thereafter. EPB has no obligation to perform any stabilization and there is no guarantee that stabilization will be undertaken. If stabilization is started, it can also be terminated at any time without notice. Under no circumstances will the transaction be carried out in order to support the market price of the shares at the price higher than the price in the Offer. EPB, acting as stabilization firm, has announced that stabilization trading has been carried out, in accordance with Article 5 (4) of the European Market Abuse Regulation 596/2014, on Nasdaq First North Stockholm as per below. Contact at EPB is Anders Kappling, tel: +46 8 463 80 00 Stabilizing Information:Issuer: ChromoGenics AB (publ) Instrument: Stocks (ISIN SE0009496268) Outcome of the Offer: 13,921,312 shares, of which stabilization max 121 312 shares Offer Price: 8.50 SEK per share Ticker: CHRO Stabilization firm: Erik Penser Bank AB (publ) Stabilizing Trading Date Quantity Price (highest) Price (lowest) Price (average)2017-03-23 85 500 8,20 6,30 6,71 2017-03-24 2 000 6,20 6,20 6,20 2017-03-27 12 000 6,80 6,30 6,60 2017-03-28 5 000 6,50 6,35 6,44 2017-03-29 812 6,55 6,40 6,46 2017-03-30 - - - - 2017-03-31 - - - - Currency for all above transactions: SEK Marketplace for all above transactions: Nasdaq First North G&W Fondkommission is the financial advisor to ChromoGenics in connection with the transaction and appointed as Certified Adviser. Contact:Thomas Almesjö, CEO Susanne Andersson, CFO & Head of CommunicationsTel: +46 18 430 0430E-mail: info@chromogenics.comThis information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and according to the Act (1991:980) regarding trading with financial instruments. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on April 3, 2017. Every care has been taken in the translation of this interim report. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenicsChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com Important informationPublication and distribution of this announcement may in certain jurisdictions be restricted by law and persons in those jurisdictions where this press release has been published or distributed should inform themselves about and observe such restrictions. The information in this press release is not an offer to purchase, subscribe for or otherwise trade in shares or other securities in ChromoGenics. This press release is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Singapore, South Africa or other country where such action would require additional measures in addition to those following Swedish law or where this would contravene the laws or regulations of that country. The information in this press release may not be forwarded, reproduced or disclosed in ways that conflict with such restrictions. Failure to comply with this instruction may result in violation of the United States Securities Act of 1933 (the "Securities Act") as amended, or applicable laws in other jurisdictions. 2017-04-03 Press release ChromoGenics publishes the annual report 2016 Regulatory information ChromoGenics AB (publ) publishes the annual report 2016 in Swedish and translated into English. ChromoGenics annual report for 2016, in Swedish and translated into English, is now available on www.chromogenics.com in pdf-format. The annual report can also be ordered in print from the company and distributed via post to shareholders on demand.The Annual General Meeting will take place Wednesday May 10th 2017 at 14.00 CET in Advokatfirman Lindahl’s offices on Vaksalagatan 10, Uppsala. Complete notifications and documents will be available at www.chromogenics.com and at the company at the time for the notice to AGM. This information is such that ChromoGenics AB (publ) is obliged to make public according to the Market Securities Act (2007:528). The information was submitted for publication, through the agency of the contact person set out below, at 08:30 CET on March 29, 2017. Every care has been taken in the translation of this interim report. In the event of discrepancies, the Swedish original will supersede the English translation. Contact:Thomas Almesjö, CEOSusanne Andersson, CFO & Head of CommunicationsTel: +46 18 430 0430E-mail: info@chromogenics.com About ChromoGenicsChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.www.chromogenics.com 2017-03-29 Press release ChromoGenics share and warrant TO1 start trading today on Nasdaq First North, Stockholm Regulatory information ChromoGenics AB (publ) shares and warrants start trading today March 23 2017 on Nasdaq First North Stockholm. ChromoGenics is a leading provider of dynamic glass for solar control. The company focuses on window and facade glass for commercial buildings and addresses architects, real estate owners and construction companies. In the recently completed rights issue (the "Offering"), a total of 13,800,000 shares and 13,921,312 TO1 were issued. The number of shares may be increased by a maximum of 121 312 for the event that it decided allotment option would be fully utilized. The price per "Unit" in the Offering consisting of one share and one TO1 amounted to SEK 8.50, corresponding to issue proceeds of SEK 117.3 million before issue costs. After completion of the Offer, the number of outstanding shares in ChromoGenics is 23,214,326 shares, prior to exercise of the over-allotment option. Shares in the Offer thus comprises approximately 59.4 percent of the total shares of the Company and the market value of the Company's shares is approximately 197.3 MSEK. The share's ticker name is CHRO, ISIN code: SE0009496268 The warrant’s ticker name is CHRO TO1, ISIN code: SE0009554470 Conditions for CHRO TO1 is that possession of four (4) TO1 entitles the holder to subscribe for one (1) new share in ChromoGenics at the rate of SEK 10.20 during the period 1 to 31 May 2018. The last trading day with TO1 is May 29, 2018. The main shareholders K-Svets Venture AB and New Energy Solutions II K/S will after completion of the Offer remain as the major shareholders of ChromoGenics. K-Svets Venture AB will hold approximately 22 percent and New Energy Solutions II K/S around 19 percent of the shares in the company. Within the framework of the Offer, the main owners converted the bridge loan of approximately 23.2 MSEK corresponding to 2,725,443 Units G&W Fondkommission is the financial advisor to ChromoGenics in connection with the transaction and appointed as Certified Adviser for the planned listing on Nasdaq First North Stockholm. This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and according to the Act (1991: 980) regarding trading with financial instruments. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 CET on March 23, 2017. Every care has been taken in the translation of this interim report. In the event of discrepancies, the Swedish original will supersede the English translation. Contact:Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) will be listed on Nasdaq First North Stockholm from March 23rd 2017. G&W Fondkommission is appointed Certified Adviser. www.chromogenics.comImportant information StabilizationIn connection with the Offering, Erik Penser can implement measures that stabilize or maintain the share price. The warrants will not in any case be subject to any stabilization measures. These stabilization measures will not be implemented at higher prices than the offer price, 8.50 SEK. Such stabilization is intended to support the market price of the shares in order to balance any sales pressure that may be present and may be implemented in a period from the first day of trading in the Company's shares on Nasdaq First North to the date that falls 30 calendar days thereafter. Stabilization Measures include transactions that stabilize, maintain or otherwise affect the market price of the shares. Stabilization transactions consist of certain bids or purchases made for the purpose of preventing or retarding a decline in the shares' market price. Erik Penser is not obliged to take stabilization measures. Thus, there is no guarantee that the stabilization measures will be taken. If stabilization measures, the measures can at any time be terminated by Erik Penser Bank decision without notice. Erik Penser Bank's acquisition of shares in connection with the stabilization measures, at Erik Penser Bank's request neutralized by a reduced allotment. Stabilization Measures should not mean that Erik Penser in total acquire more than 121,312 shares. Neutralization by reducing the allotment may result in the number of warrants issued can not exceed the number of shares issued under the Offer up to 121,312. Within one week after the end of the period during which stabilization measures can be taken, it will be published by Erik Penser whether stabilization measures were carried out or not, the date on which stabilization started, the date of the last stabilization operation was performed and the price range within which stabilization was carried out (for each of the dates during which stabilization measures were carried out). 2017-03-23 Press release Trading in ChromoGenics starts at Nasdaq First North on March 23 after approved listing application Regulatory information ChromoGenics AB (publ), a leading provider of dynamic glass with controllable heat- and light transmission for solar control and energy efficiency, implements listing of shares and warrants on Nasdaq First North after approved listing application. The first trading day for the shares and the warrants will be March 23rd 2017. Ahead of the listing, ChromoGenics completed an oversubscribed issue of new shares bringing in 117.3 MSEK, before deduction of issue expenses and settlements of shareholder loans and guarantee fees. In addition, up to 1 MSEK may be subject to normal market stabilization and / or involve the use of over-allotment option. ChromoGenics receive in connection with the rights issue just over 2100 new shareholders. G&W Fondkommission is the financial advisor to ChromoGenics in connection with the transaction and appointed as Certified Adviser for the planned listing on Nasdaq First North Stockholm. This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 CET on March 20, 2017. Every care has been taken in the translation of this interim report. In the event of discrepancies, the Swedish original will supersede the English translation. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share will be listed on Nasdaq First North Stockholm from March 23rd 2017. G&W Fondkommission is appointed Certified Adviser. www.chromogenics.com 2017-03-20 Press release Year-End Report 2016 Regulatory information Fourth quarter of 2016 Revenue amounted to SEK 0.3 (0.0) million from a few smaller initial projects, one of which was an expansion project related to one of the first project orders. The ConverLight™ product is generating considerable interest among property owners, architects and other players in the flat glass market. The net income for the period amounted to SEK -11.7 (-13.0) million, corresponding to SEK -0.64 (-2.01) per share. The company is a development company in the process of transforming itself into a sales and production company. Sales are initially low and thus do not cover the company’s total expenses. Cash and cash equivalents at the end of the period amounted to SEK 8.5 (10.9) million. Reported equity at the end of the period amounted to SEK -36.0 (-10.5) million. On October 5, a large number of employees at ChromoGenics were given notice. The company is entering into a new phase as it transforms itself from a development company into a sales and production company. Six staff members were made redundant on November 11 and two staff members had decided to leave the company on their own accord after September 30. The change will create a more cost-effective organization. Restructuring expenses of SEK 1.6 million were charged to earnings. The savings will be realized progressively during the first half of 2017. On November 16, an increase to the share capital of SEK 7.9 million from a new share issue was registered, corresponding to 2,921,472 new shares. In total, SEK 4.0 million was paid in September and SEK 3.9 million in October. On November 17, 2016, an increase in the share capital was registered through the exercise of three warrant programs. In total, 982,602 options were exercised, corresponding to 982,602 new shares, totaling SEK 2.7 million. The total number of shares amounted to 18,828,653 after the above issue and exercise of options, corresponding to share capital of SEK 1,882,865.30. On November 21, Micael Hamberg became the Chief Operation Officer (COO) and has primary responsibility for the company’s supply chain. Hamberg will join the management team and focus on customers, quality and delivery precision. In July, a loan of SEK 5 million was provided from one of the main owners at an interest rate of 5% and a maturity date of December 31, 2016. In December the maturity date was extended to February 28, 2017. In conjunction with the loan, a floating charge of SEK 5 million was pledged to the lender. The loan, including the interest, was converted to new shares in combination with the issue of new shares that was concluded in the beginning of March. As at the balance sheet date, ChromoGenics AB did not have sufficient liquidity to cover its expenses for the next 12 months. A short-term financing from the main owners was completed in December for a total of SEK 18.0 million, of which SEK 9.0 million was paid in December and another SEK 9.0 million was paid in January 2017 to cover the finance need until the completion of the issue of new shares of SEK 117 million when the short-term financing was converted into new shares. For more information, refer to Cash flow and financial position in this report. January – December 2016 Revenue amounted to SEK 3.0 (0.0) million. The ConverLight™ product was commercialized during the year and the first deliveries began during the summer. There is considerable interest and a number of discussions and negotiations are ongoing. The net income for the period amounted to SEK -49.5 (-43.5) million, corresponding to SEK -3.80 (-8.82) per share. Following a resolution by an extraordinary general meeting in December 2015, a 27:1 reverse split was registered in January 2016, after which the number of registered shares amounted to 9,820,478. At a meeting of the Board of Directors on February 24, 2016, a decision was made regarding the issue of shares. A new share issue brought in SEK 13.8 million, corresponding to 5,104,101 shares. The new share issue was registered in June 2016. The total number of shares after registration was 14,924,579. At the Annual General Meeting on June 20, 2016, Anders Brännström was re-elected Chair of the Board and Poul Erik Schou-Pedersen and Claes-Göran Granqvist were re-elected members of the Board. Jerker Lundgren was elected member of the Board. The Meeting resolved to release the Board of Directors and the CEO from liability for the 2015 financial year. Important events after the end of the period At an extraordinary general meeting held on January 12, 2017, resolution was passed on the following: Change in company category from a private to a public limited liability company 2:1 reverse split. The total number of shares after the reverse split is 9,414,326 with a share capital of SEK 1,882,865.30. New Articles of Association On February 8, 2017, the company announced that it is applying for a listing on Nasdaq First North and published a prospectus with the intention of conducting a new share issue for institutional investors and the general public in Sweden of SEK 117.3 million, excluding a potential over-allocation option of SEK 12.7 million. At the time of the announcement, subscription agreements from major shareholders as well as guarantees through a guarantee consortium had been obtained, representing 82 per cent of the issue and SEK 96 million. On February 21, 2017 an announcement was made of a major order to deliver dynamic glass to Fabege's project the Grand Central Sundbyberg, Stockholm. On February 22, 2017 an announcement was made of a Prospectus Supplement to the Prospectus dated February 8, 2017. On March 3, 2017 it was announced that ChromoGenics’ issue of new shares oversubscribed and that it will provide the company with approximately SEK 119 million, of which 117.3 million correspond to the basic offer. The settlement is expected to be paid on March 8, 2017 to the Company, excluding transaction costs and conversions of shareholder loans and guarantee fees. Excess amounts of 117.3 million, may be subject to normal market stabilization and / or involve the use of over-allotment option. No allocation has thus been made to the consortium that guaranteed the new share issue for approximately SEK 41 million, on top of the subscription agreements, up to a total subscription rate of 90 percent. The issue of new shares will provide the company with over 2,000 new shareholders. The number of outstanding shares in ChromoGenics will increase, under the implementation of the basic offer, from 9,414,326 to 23,214,326. Trading in shares and warrants will commence March 23, 2017, provided an approved listing application. This report discusses the development for the period October-December 2016 compared to the same period in 2015, unless otherwise stated. Comments from the CEO After successful development of technology, products and production processes, ChromoGenics is now fully committed to a commercialization, moreover, as a public company. We are extremely pleased that so many have shown interest to subscribe for shares in our company in connection with the issue of new shares of SEK 117 million which was oversubscribed and completed in early March. It feels fantastic to launch the next phase of ChromoGenics. We will create value for both customers and shareholders and other stakeholders through the full-scale launch of our dynamic glass that makes buildings more attractive by saving energy and significantly increasing indoor comfort. Our dynamic ConverLight™ glass offers property owners, architects, construction companies and players in the glass industry cost-efficient solar protection. Daylight and contact with the surroundings raise the level of comfort and well-being. ConverLight™ controls the heat- and light transmission while still offering daylight and a full view of the surroundings. With ConverLight™, customers can lower costs more than with traditional external solar protection, which is exposed to sun and wind and thus requires maintenance. The investment in our technology results in lower maintenance costs, as well as in improved energy efficiency and indoor comfort. Moreover, our technology and business model facilitate efficient, sustainable distribution around the world. If you want to maximize a building’s energy efficiency, it should not have windows, glass facades or glass ceilings. But what we are seeing today is that the trend in architecture is moving in the opposite direction toward more windows and glass. People need daylight and contact with their surroundings to feel good, and property owners and project developers want to offer attractive properties. ChromoGenics’ dynamic glass offers cost-efficient control of heat- and light transmission, which means that energy consumption for cooling can be reduced while at the same time enabling architectural freedom and contact with the surroundings. Demand for dynamic glass is growing due to a greater focus on sustainability. If the EU is to be able to meet the climate target of a 20-percent reduction in energy consumption and greenhouse gas emissions by 2020, it will be necessary to make buildings more energy-efficient. Since a large part of energy consumption as a whole is related to the warming up and cooling down of buildings, the construction sector will play a crucial role in meeting the climate targets. ConverLight™ helps buildings achieve energy certification, such as Miljöbyggnad, LEED and BREEAM. Market surveys show that the market for dynamic glass could dramatically increase in the next few years due to the focus on energy efficiency and new opportunities such as the Internet of Things (IoT). ChromoGenics is in a very interesting phase with many opportunities to position itself as a leader in the market. We have already begun production and sales of our dynamic ConverLight™ glass in the Nordic market. The glass has been installed in both Sweden and Norway and we have received confirmation that our offer works all the way to final installation at the customer site. Through the company’s establishment on the market, we have also learned a lot about delivery and production processes, from which we can benefit in the future. Extensive resources and time have been invested to reach the position we are at today. A recent reorganization of the operations to more clearly focus on sales and production is creating good conditions for continued commercialization and future profitability. We will now target our resources to achieve a rapid expansion by continuing to invest in sales and production. Join us on our journey! Thomas Almesjö, CEO This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 09:30 CET on March 8, 2017. Every care has been taken in the translation of this interim report. In the event of discrepancies, the Swedish original will supersede the English translation. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communication Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started sales and deliveries to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The company has about 20 employees and the main owners are K-Svets Venture AB and New Energy Solutions II K/S. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. www.chromogenics.com 2017-03-08 Press release ChromoGenics issue of new shares oversubscribed - brings in 117.3 MSEK and more than 2 000 new shareholders Regulatory information ChromoGenics AB brings in 117.3 MSEK and more than 2 000 new shareholders through a now completed issue of new shares in combination with the company’s plan to list at Nasdaq First North Stockholm March 23rd 2017. The issue of new shares in ChromoGenics has been well received in the market and the board has decided to allocate about 119 MSEK, of which 117.3 MSEK correspond to the basic offer that will be added to ChromoGenics, before deduction of issue expenses and settlements of shareholder loans and guarantee fees. Excess amounts may be subject to normal market stabilization and / or involve the use of over-allotment option. No allocation has thus been made to the consortium which guaranteed issue up to a 90 percent subscription rate. "We are extremely pleased that so many have shown interest to subscribe for shares in our company. It is positive that the dynamic glass creates such a great interest both commercially and from an environmental and sustainability perspective," says Anders Brännström, Chairman of ChromoGenics. "It feels fantastic to launch the next phase of ChromoGenics development, both the public and the commercial phase. We will create value for both customers and shareholders through the full-scale launch of our dynamic glass that makes buildings more attractive by saving energy and significantly increasing indoor comfort, "says Thomas Almesjö, CEO of ChromoGenics. The number of outstanding shares in ChromoGenics will increase by the implementation of the basic offer from 9 414 326 to 23 214 326. A possible extension of the Offer by any exercise of the Over-Allotment Option will be announced through a press release at a later date. Payment for the Units shall be made according to instructions on the contract note, planned for March 8, 2017. Shares and warrants will be delivered to the respective securities accounts when these are registered by the Swedish Companies Registration Office (Bolagsverket), which is expected to occur on or about March 17, 2017. Trading in the shares and warrants is planned to commence at March 23, 2017, provided an approved listing application. The terms of the warrants is that four warrants entitle the holder to subscribe for one new share in ChromoGenics during the period 1-31 May 2018 at a price of 10.20 SEK. Upon exercise of the warrants under the basic offer, ChromoGenics will bring in approximately 35.2 MSEK through the issuance of an additional 3 450 000 shares, representing a dilution of a maximum of 12.9 percent. ChromoGenics has appointed G&W Fondkommission as Certified Adviser for the planned listing on First North at NASDAQ Stockholm. G&W Fondkommission is the financial advisor to ChromoGenics in connection with the transaction. This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 CET on March 3, 2017. Every care has been taken in the translation of this interim report. In the event of discrepancies, the Swedish original will supersede the English translation. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communication Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started sales and deliveries to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The company has about 20 employees and the main owners are K-Svets Venture AB and New Energy Solutions II K/S. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. www.chromogenics.com 2017-03-03 Press release ChromoGenics publishes a supplement to the prospectus in connection with the listing on Nasdaq First North NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, NEW ZEELAND, JAPAN, CANADA, HONG KONG, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH MEASURE IS SUBJECT TO LEGAL RESTRICTIONS. PLEASE ALSO REFER TO THE SECTION IMPORTANT INFORMATION BELOW. ChromoGenics AB (publ) has published a prospectus supplement to the prospectus regarding the invitation to subscribe for Units in ChromoGenics in connection with the listing on Nasdaq First North which was approved and registered by the Swedish Financial Supervisory Authority on 8 February, 2017. The Prospectus Supplement is part of, and shall be read together with, the Prospectus. The Prospectus Supplement has been prepared due to the fact that ChromoGenics board of directors may settle the guarantee compensation to the guarantors by means of a directed issue of maximum 500,000 shares and, in accordance with the provisions of the Offer, by allotment of one warrant for each share without consideration (together one “Unit”). In total, a maximum of 500,000 Units can be allotted to the guarantors as guarantee compensation. The Prospectus Supplement has today been approved by the Swedish Financial Supervisory Authority and is available at www.chromogenics.com. Investors who, prior to the publication of the Prospectus Supplement, have notified or otherwise agreed to subscribe for Units in the Offer are, in accordance with Chapter 2, Section 34, of the Swedish Financial Instruments Trading Act (1991:980), entitled to withdraw their notification or consent within two working days from the publication of the Prospectus Supplement, i.e. on 24 February 2017 at the latest. The withdrawal must be made in writing and submitted to Aktieinvest FK AB, Emittentservice, 113 89 Stockholm, Sweden. Investors who have subscribed through a nominee should contact their nominee regarding withdrawal. Subscriptions that are not withdrawn will remain in force. Should subscribers wish to remain as subscribers no action is required. FINANCIAL ADVISOR: G&W Fondkommission is the financial advisor in connection with the Offer and will be the company’s Certified Advisor on Nasdaq First North. Hannes Snellman Attorneys Ltd is the legal advisor in relation to Swedish law in connection with the offer. This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 12:00 CET on February 22, 2017. CONTACT: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: infoo@ochromogenics.com IMPORTANT INFORMATION This document has not been approved by any regulatory authority. The document is a press release and not a prospectus and investors should not subscribe for or purchase any securities referred to in this document except on the basis of the information contained in the prospectus which has been approved by the FSA and will be available on the company website. The distribution of this announcement in certain jurisdictions may be restricted by law, and persons who access it or any part of it, should inform themselves and observe such restrictions. This press release shall not constitute an offer to sell or a solicitation to buy shares, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would require preparation of additional prospectuses or other documentation, or be unlawful prior to registration or applicable exemption from registration under the securities laws of such jurisdiction. This press release does not constitute or form part of, an offer or the solicitation of an offer to buy or subscribe for securities in the United States. The securities mentioned herein have not been and will not be registered under the US Securities Act of 1933 (the "Securities Act") and may not be offered or sold in the United States absent registration under the Securities Act, or an exemption therefrom. The securities mentioned herein are not offered to the public in the United States. Copies of this announcement are not being, and must not be distributed or sent, in whole or in part, directly or indirectly, in Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or the United States or any other jurisdiction where such distribution and the mailing of this press release would be unlawful. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started sales and deliveries to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The company has about 20 employees and the main owners are K-Svets Venture AB and New Energy Solutions II K/S. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. www.chromogenics.com 2017-02-22 Press release ChromoGenics receives a larger order to provide dynamic glasses to Fabege’s sustainable Grand Central Project in Sundbyberg, Stockholm. Regulatory information ChromoGenics has been selected to provide dynamic glass to the sustainable Grand Central Project in Sundbyberg, Stockholm. The real estate project will meet the requirements for sustainability certification system BREEAM-SE, level "Very Good”, where ChromoGenics’ dynamic glass contributes to improved energy efficiency and indoor comfort. ChromoGenics will deliver its product ConverLight™ dynamic glass to Fabege’s Grand Central Project in Sundbyberg, Stockholm, Sweden. ConverLight™ provides with sustainable solar control. Deliveries are planned to first half of 2017 and the opening of the property is planned to second half of 2018. “We are proud to be a part of a project using the world’s longest established method of certifying the sustainability of buildings, and using the latest technology, says Thomas Almesjö, CEO ChromoGenics. “Daylight and contact with the outside surroundings improves comfort and well-being. ConverLight™ controls heat- and light transmission while maintaining daylight and view to the outside world. In addition, ConverLight™ contributes to lower maintenance costs as well as green building certifications, which is on top of the agenda to reach the European environmental goals of reducing carbon dioxide emissions by 20% by year 2020,” concludes Thomas Almesjö. “We are pleased to offer modern, flexible and business-friendly offices in the heart of Sundbyberg, Stockholm. All office areas will have the latest technical solutions for optimal comfort and energy savings, including new air condition solutions connected to ChromoGenics’ façade glass for dynamic solar control. The façade will vary to distinguish the large surfaces, while indoor will have a modern design, including sustainable materials with low environmental impact,” says Per Lindfors, Project Manager at Fabege. “ConverLight dynamic glass was chosen due to its flexible architectural design as well as the benefits in terms of energy efficiency and indoor comfort. This is a perfect solution since carbon dioxide footprint and sustainability is on top of our agenda. We are proud to be one of the first in Sweden to provide with dynamic glass to help reach the environmental goals,” concludes Per Lindfors. For more information about Grand central Sundbyberg see: http://www.fabege.se/orgeln This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 CET on February 21, 2017. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communication Tel: +46 18 430 0430 E-mail: infoo@ochromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started sales and deliveries to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The company has about 20 employees and the main owners are K-Svets Venture AB and New Energy Solutions II K/S. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. www.chromogenics.com About Fabege: Fabege is a property company focusing on urban development and commercial properties. We work with strategic partners to develop attractive and sustainable city districts with modern offices, residential units and a wide range of services. We have a long-term perspective and approach to ownership, and we are passionate about creating the right conditions for everyone living, working and spending time in our areas. We can be found in a select number of fast-growing submarkets in the Stockholm area. Fabege’s shares are listed on Nasdaq Stockholm, in the Large Cap segment. For further information, visit www.fabege.com Contact: Pernilla Arwidson, Communication Large Projects Tel: +46 (0)72-546 34 02 E-mail: pernilla.arwidsono@ofabege.se 2017-02-21 Press release ChromoGenics announces its intention to launch an initial public offering and listing on Nasdaq First North and publishes prospectus Regulatory information ChromoGenics AB (publ), a leader within dynamic glass, has decided to launch an initial public offering and listing on Nasdaq First North. At the same time, a rights issue of 117 MSEK to institutional investors and general public in Sweden is being implemented. ABOUT CHROMOGENICS AND THE OFFERING ChromoGenics offers dynamic glass with controllable optical properties. The company’s unique electrochromic technology ConverLight™, provides dynamic solar control with increased indoor comfort and energy efficiency. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University, Sweden. In 2016 the company began commercial sales and deliveries to real estate projects in Scandinavia. Sales and deliveries are estimated to continue to grow during 2017 with increasing volume sales and improving financial results in subsequent years. The market for dynamic glass is estimated to show strong growth the coming years according to the American industry analyst firm n-tech Research; ”ChromoGenics is likely to make a major contribution to the installed base of EC windows for commercial buildings going forward, but is just ramping up production” - n-tech Research on smart windows markets: 2016-2025, Nov 2016. “ChromoGenics is a leading provider of dynamic glass for windows, facades and roofs for commercial real estate. Our product ConverLight™ makes buildings more attractive by providing high tech solar control for increased indoor comfort and energy efficiency as well as lower maintenance costs” says Thomas Almesjö, CEO ChromoGenics. “After extensive investments in innovation and development, our product is now in the beginning of an exciting commercialization period. The product is sustainable and cost efficient, which makes it a competitive alternative for awnings, mechanical shades and other exterior solar protection. We have over the last years developed the business, established large-scale production and our main focus is now customers, quality and delivery precision. The initial purchase offer and listing at Nasdaq First North will enable us to continue our product development, expand our operations and strengthen our offering to customers and other stake holders” concludes Thomas Almesjö. The Offering constitutes of a maximum of 13.800.000 new shares in ChromoGenics AB (publ), which will add some SEK 117 m. in funding to the Company. The Board of Directors has granted an overallotment option to the adviser that can add an additional 1.500.000 new shares to the Offering, equivalent to about SEK 13 m. The issue is pre-subscribed and guaranteed up to 11.347.000 shares which corresponds to an amount of SEK 96 m., SEK 55 m. and SEK 41 m. respectively, by the largest shareholders, K-Svets Venture AB and New Energy Solutions II K/S, and by a consortium of professional investors. Net proceeds will finance intensified sales- and marketing activities, continued product development and investments in production facility to increase capacity. It will also finance the working capital and strengthen the balance sheet to enable the company to accelerate its future expansion. First day of trading is scheduled for March 23, 2017, provided that ChromoGenics is approved by Nasdaq First North for admission to trading, which implies that the distribution requirement must be met. The subscription period runs from 9 to 24 February 2017 FINANCAIL ADVISOR: G&W Fondkommission is the financial advisor in connection with the Offer and will be the company’s Certified Advisor on Nasdaq First North. FOR MORE INFORMATION: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications +46 (0)18 430 04 30 info@chromogenics.com IMPORTANT INFORMATION This document has not been approved by any regulatory authority. The document is a press release and not a prospectus and investors should not subscribe for or purchase any securities referred to in this document except on the basis of the information contained in the prospectus which has been approved by the FSA and will be available on the company website. The distribution of this announcement in certain jurisdictions may be restricted by law, and persons who access it or any part of it, should inform themselves and observe such restrictions. This press release shall not constitute an offer to sell or a solicitation to buy shares, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would require preparation of additional prospectuses or other documentation, or be unlawful prior to registration or applicable exemption from registration under the securities laws of such jurisdiction. This press release does not constitute or form part of, an offer or the solicitation of an offer to buy or subscribe for securities in the United States. The securities mentioned herein have not been and will not be registered under the US Securities Act of 1933 (the "Securities Act") and may not be offered or sold in the United States absent registration under the Securities Act, or an exemption therefrom. The securities mentioned herein are not offered to the public in the United States. Copies of this announcement are not being, and must not be distributed or sent, in whole or in part, directly or indirectly, in Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or the United States or any other jurisdiction where such distribution and the mailing of this press release would be unlawful. 2017-02-08 Press release PRESS RELEASE: Micael Hamberg appointed COO at ChromoGenics ChromoGenics is expanding the manufacturing, marketing and sales activities for its ConverLight™ dynamic glass. Micael Hamberg has been appointed Chief Operating Officer of ChromoGenics and will be part of the company’s executive management team. Micael has a M.Sc. in Physics and a MBA in international business from Uppsala University and more than 20 years of experience from a number of management positions within operations from medical device, electromechanical, and IT industry, including startup companies. His most recent position was as Head of engineering at Munters, a global leader in energy efficient air treatment solutions. “We are delighted to welcome Micael to our team. Micael has a well-proven background from different industries which will further strengthen our management team,” says Thomas Almesjö, CEO of ChromoGenics. “This is particularly important for ChromoGenics as we are expanding the production capabilities and our main focus is customers, quality and delivery precision of our ConverLight™ dynamic glass for the commercial buildings market.” For further information, please contact: Thomas Almesjö, CEO ChromoGenics, and Tel 46 18 430 04 50 E-mail: info@chromogenics.com 2016-11-21 Press release PRESS RELEASE: ChromoGenics showcases the dynamic glass at Glasstec 2016. ConverLight™ Dynamic Glass enables designers to use more glass while still meeting the performance objectives of building energy codes and standards. ChromoGenics is showcasing the dynamic glass ConverLight™ at the Glasstec exhibition in Germany September 20-23. “We are delighted to present the smart glass ConverLight™ at the trade show in Düsseldorf,” says Thomas Almesjö, CEO at ChromoGenics. “There is a great interest for advanced materials that support sustainable buildings. Our dynamic glass enables freedom in design for creative architects and in building projects.” ConverLight is a flexible, dynamic glass solution providing effective solar protection for increased indoor comfort and energy efficiency. The windows adapt automatically or manually to daylight and solar radiation, without any external equipment interfering with the view or changing the esthetic appearance of the building façade. ChromoGenics’ unique, proprietary electrochromic technology controls optical properties, shifting transparency between lighter or darker. Energy savings come from reduced needs for air conditioning, since the surplus solar radiation can be reduced up to 90% by dynamically shading the glass. It contributes to fulfilling the requirements of environmental building certifications, such as LEED and BREEAM. Glasstec is an international trade fair that has over 1200 exhibitors and over 40 000 visitors from 87 countries. The exhibition is held every second year in Düsseldorf, Germany. Welcome to visit us in hall 11 stand A31 during the Glasstec exhibition. 2016-09-20 Press release PRESS RELEASE: ChromoGenics inaugurates new plant for producing ConverLight™ dynamic glass With a crowd drawn from industry and academia, ChromoGenics today inaugurated its new manufacturing facility in Uppsala, Sweden. The 3000 sqm production facility includes climate-stabilized cleanroom facilities, production lines for ConverLight™ glass laminates, testing facilities and a center for high-tech smart materials. Distinguished guests included Erik Brandsma, Director General of the Swedish Energy Agency, who formally inaugurated the plant, and Professor Claes-Göran Granqvist, one of the founders of ChromoGenics, who is the pioneer behind much of the research on dynamic glass. In his remarks to the audience, CEO Thomas Almesjö stressed the significance of the event: “Our new plant, based on nanomaterials research from Uppsala University in Sweden, represents the start of a whole new industry for sustainable glass solutions.” Production is now beginning in the plant to fulfill orders for Scandinavian architectural projects, and deliveries will take place during 2016. These building projects represent only a small part of the potential global demand real estate and construction companies as well as other players within the glass industry. ConverLight™ is a flexible, dynamic glass solution providing effective solar protection for increased indoor comfort and energy efficiency. The windows adapt automatically or manually to daylight and solar radiation, without any external equipment interfering with the view or changing the esthetic appearance of the building façade. ChromoGenics’ unique, proprietary electrochromic technology controls optical properties, shifting transparency between lighter or darker. Energy savings come from reduced needs for air conditioning, since the surplus solar radiation can be reduced up to 90% by dynamically shading the glass. It contributes to fulfilling the requirements of environmental building certifications, such as LEED and BREEAM. 2016-05-25 Press release PRESS RELEASE: ChromoGenics recognized as Nanotechnology Company of the Year for its ConverLight™ dynamic glass In front of an audience of industrial companies, researchers, policy makers, members of parliament and venture capitalists, ChromoGenics received the Nanotechnology Company of the Year Award from SwedNanoTech, Sweden’s first umbrella organization for its nanotechnology industry. The award took place on Friday, May 20 at Nano Forum 2016, the fifth edition of Sweden’s largest conference on nanotechnology, advanced materials, and business opportunities, held at the Royal Swedish Academy of Engineering Sciences (IVA). The award was based on the firms’ nanotech content, customers & sales, business plan, finances and scalability. The jury’s decision cited the following in granting the award to ChromoGenics: “The ability to control a window’s transparency is an excellent example of application of nanotechnology as a means for energy saving and better indoor climate. With a clear customer focus and strong IP strategy, ChromoGenics will introduce a paradigm shift to a traditional industry.” Thomas Almesjö, CEO of ChromoGenics, stressed the importance of providing the right conditions to top-level Swedish academic research for global commercialization: “ChromoGenics, based on leading research at the Ångström Laboratory at the University of Uppsala, is now taking its technology to the next phase, industrial production and commercialization. Meeting worldwide demand for dynamic glass is not just about perfecting the right technology, but also developing the right business model to take advantage of technical advances. At ChromoGenics we are now launching our ConverLight™ product in a way that takes advantage of existing supply chains and makes them more efficient.” ConverLight is a flexible, dynamic glass solution providing effective solar protection for increased indoor comfort and energy efficiency. The windows adapt automatically or manually to daylight and solar radiation, without any external equipment interfering with the view or changing the esthetic appearance of the building façade. ChromoGenics’ unique, proprietary electrochromic technology controls optical properties, shifting transparency between lighter or darker. Energy savings come from reduced needs for air conditioning, since the surplus solar radiation can be reduced up to 90% by dynamically shading the glass. It contributes to fulfilling the requirements of environmental building certifications, such as LEED and BREEAM. Production is already at high tempo in the plant to fulfill orders for several Scandinavian architectural façade projects, and initial deliveries will take place during 2016. 2016-05-23 Press release PRESS RELEASE: ChromoGenics has appointed Peter Lundh as Head of Sales ChromoGenics is initiating manufacturing, marketing and sales activities for its unique ConverLight™ dynamic glass for architectural applications. Sales activities at ChromoGenics are managed by Peter Lundh, Head of Sales for Architectural Applications. Peter has more than 20 years’ experience in sales, marketing and business development, and has spent the past ten years in the building and glass industry. He came to ChromoGenics from a position as Swedish Country Manager for Vetrotech Saint-Gobain, which handled high-performance specialty glass, primarily for fire and security applications. Peter holds a degree in Marketing Management & Economics from IHM Business School. “ChromoGenics has marked the entry into a new phase of commercialization, as our manufacturing operations will be filling orders for our ConverLight™ dynamic glass,” says Thomas Almesjö, CEO of ChromoGenics. “There is a tremendous potential global demand for smart windows from forward-looking architects and building owners. We are pleased to have Peter Lundh with us to run our sales operations in this important market, as his long experience in the building and glass industry is now focused on the most advanced smart window technology available today.” 2016-04-13 Press release PRESS RELEASE: Iréne Öhman appointed Marketing Communications Manager at ChromoGenics Iréne Öhman has been appointed Marketing Communications Manager at ChromoGenics, with responsibilities for developing and implementing the communications strategy, which includes a wide variety of different channels to raise awareness of ChromoGenics and its products. Iréne has held similar positions with a number of technical and industrial firms, where she was responsible for international marketing, coordinating with sales teams in Europe and Asia. Her most recent position was Marketing Communications Manager at Habia Cable. “We are pleased to welcome Iréne to our team. With her international industrial experience, Iréne is joining us at a critical time where her skills and expertise will make a difference,” says Thomas Almesjö, CEO of ChromoGenics. “ChromoGenics is entering the commercialization phase and rapidly expanding its reach in many marketplaces, as well as deepening relations with commercial partners.” For further information, please contact: Thomas Almesjö, CEO ChromoGenics, Tel: +46 18 430 04 50 E-mail: info@chromogenics.com 2016-03-22 Press release PRESS RELEASE: Susanne Andersson appointed new CFO at ChromoGenics Susanne Andersson has been appointed new CFO of ChromoGenics and will be part of the company’s executive management team. Susanne has an international Bachelor of Business Administration from the US and 20 years’ international experience from a number of financial management positions, including CFO and investor relations roles within the telecom, mining and logistics industries. Her most recent position was VP, Head of Investor Relations at PostNord. “We are delighted to welcome Susanne to our team. Susanne has a well-proven background in financial management and analysis as well as a broad understanding of financial markets, which will further strengthen our management team,” says Thomas Almesjö, CEO of ChromoGenics. “This is particularly important to ChromoGenics as we are entering the commercialization phase and are starting deliveries of smart windows to the commercial buildings market.” For further information, please contact: Thomas Almesjö, CEO at ChromoGenics, Tel: +46 18 430 04 50 E-mail: info@chromogenics.com ChromoGenics is a global leader in developing and producing dynamic glass that saves energy and increases comfort. Our unique, proprietary electro chromic technology makes it possible to produce glass with controllable optical properties – it becomes lighter or darker by supplying a small electric current. We call our smart glass ConverLight™. ChromoGenics is located in Uppsala, Sweden. The current 3000 m² production facility includes climate-stabilized cleanroom facilities, production lines for ConverLight glass laminates and testing, a center for high-tech smart materials. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics was founded in 2003, building on more than 20 years of research on electrochromic materials at the Ångström Laboratory at Uppsala University. The company has more than 20 employees and the main investors are K-Svets Förvaltning (owner of Skandinaviska GlasSystem), NES Partners and Volvo Group Venture Capital. 2016-03-14 Press release ChromoGenics ABUllforsgatan 15SE-75228Uppsala, Swedeninfo@chromogenics.com+46 (18) 430 04 30Legal Notice